计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Galidesivir (BCX4430) hydrochloride, an adenosine analog and a direct-acting antiviral agent, disrupts viral RNA-dependent RNA polymerase (RdRp) activity. Galidesivir hydrochloride is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV, SARS-CoV , and SARS-CoV-2. Galidesivir hydrochloride inhibits some negative-sense RNA viruses with EC 50 s ranging from ~3 to ~68 μM
In Vitro
Cellular kinases phosphorylate Galidesivir (BCX4430) hydrochloride to a triphosphate that mimics ATP; viral RNA polymerases incorporate the drug's monophosphate nucleotide into the growing RNA chain, causing premature chain termination. ?\nGalidesivir hydrochloride effectively inhibits the infection of Vero cells with YFV. The EC 50 determined by the neutral red uptake assay is 8.3 μg/ml (24.5 μM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Galidesivir (BCX4430) hydrochloride is active after intramuscular, intraperitoneal, and oral administration in a variety of experimental infections. In nonclinical studies involving lethal infections with Ebola virus, Marburg virus, Rift Valley fever virus, and Yellow Fever virus, Galidesivir hydrochloride has demonstrated pronounced efficacy . ?\nGalidesivir hydrochloride (4 mg/kg; i.p.; twice daily for 7 days) is effectively in a hamster model of yellow fever (YF). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female Syrian golden hamsters (hamsters infected with YF virus)Dosage: 4 mg/kg of body weight Administration: I.p.; twice daily for 7 days Result: Significantly improved the survival of hamsters infected with YFV.
Form:Solid
IC50& Target:RdRp inhibitor
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 吡咯并嘧啶 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 吡咯并嘧啶 |
| 其他上位类(Alternative Parents) | 芳烷基胺 氨基嘧啶及其衍生物 取代吡咯 咪唑内酰胺类 吡咯烷 杂芳族化合物 仲醇 1,2-氨基醇 二烷基胺 氮杂环化合物 伯胺 伯醇 盐酸盐 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1,2-氨基醇 - 羟基苯甲酸酯 - 氨基酸 - 氨基吡啶 - 芳烷基胺 - 芳香族杂多环化合物 - 氮杂环 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 咪唑内酰胺 - 有机硝基化合物 - 有机氧化合物 - 有机氮化合物 - 有机氧化合物 - 初级醇 - 初级胺 - 嘧啶 - 吡咯 - 吡咯烷 - 吡咯吡啶 - 醛基 - 二级脂肪胺 - 醛基 - 取代吡咯 |
| 描述(Description) | 该化合物属于吡咯嘧啶类有机化合物。这类化合物含有吡咯嘧啶结构单元,即吡咯环与嘧啶环共轭形成的结构。吡咯为五元环,由四个碳原子和一个氮原子构成;嘧啶为六元环,由四个碳原子及位于1位和3位的两个氮原子中心构成。 |
| 外部描述符(External Descriptors) | 暂无 |